Trials / Conditions / Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
4 registered clinical trials studyying Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL NCT05149170 | Chinese Academy of Medical Sciences | Phase 2 |
| Unknown | Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL NCT05254899 | Chinese Academy of Medical Sciences | Phase 2 |
| Unknown | PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma NCT02085655 | Huiqiang Huang | Phase 3 |
| Completed | Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma NCT01238159 | Samsung Medical Center | Phase 2 |